Table 1.
(a) At age 18–24 months (3 or 4 doses) | ||||||||
---|---|---|---|---|---|---|---|---|
Region | 1999 | 2000 | 2003 | 2005 | 2006 | 2008 | 2009 | |
Wallonia | 50·2* | 64·8* | 92·7* | 90·4† | ||||
Flanders | 68·4* | 92·2† | 95·1† | |||||
Brussels | 42·1* | 88·4† | ||||||
(b) In school-aged children (3 doses) | ||||||||
Region | Age (yr) | Survey (cohort)‡ | 2000 (1988) | 2001 (1989) | 2004 (1992) | 2005 (1997 + 1991) | 2006 (1994) | 2008 (1994) |
Wallonia | 11–12 | 41·4 | 37·1 | 64·2 | 68·6 | |||
Flanders | 7–8 | 72·0 | ||||||
Flanders | 14 | 75·7 | 89·2 |
EPI, Extended programme of immunization.
Third dose coverage.
Fourth dose coverage.
Year of birth of the majority of the surveyed children. In the French community, school-based surveys included children in the 6th year of primary school regardless of their year of birth, whereas in the surveys in Flanders children were primarily selected based on their year of birth. Adolescents were invited for HBV vaccination in the last year of primary school in Wallonia, and in the first year of secondary school in Flanders.